Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients.

Han, Ling; Gan, Yixiao; Du, Juan; Hu, Yao; Chen, Yanwen; Huang, Qiong; Zhang, Zhenghua; Yawalkar, Nikhil; Yan, Kexiang; Wang, Zhicheng (2024). Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients. Journal of dermatological treatment, 35(1) Taylor & Francis 10.1080/09546634.2024.2377665

[img]
Preview
Text
Evaluation_of_2-microglobulin_in_the_condition_and_prognosis_of_psoriasis_patients.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC).

Download (1MB) | Preview

BACKGROUND

Numerous studies have linked the inflammatory pathway in psoriasis and metabolic disease, while no specific marker defined it. It is worth exploring the association of β2-microglobulin (β2M) in psoriasis severity and comorbidities.

OBJECTIVES

To investigate the correlation between blood β2M level and psoriasis severity, to explore the inflammatory factors influencing the occurrence of psoriasis comorbidities such as arthritis, diabetes, and hypertension.

METHODS

Ninety-seven psoriasis patients were analyzed in the cohort retrospective study during 12 weeks.

RESULTS

Significantly higher levels of blood β2M and ESR were observed in the group that patients' PASI ≥10 than in the group that PASI <10. Blood β2M level had strong significantly positive correlations with the PASI in Pearson's correlation analysis. In the model that systemic inflammatory factors to find psoriasis comorbidity risk factors, logistic regression analysis showed that blood β2M level was the significant risk factor associated with diabetes and hypertension. High-sensitivity C-reactive protein (hsCRP) was the significant risk factor associated with arthritis.

CONCLUSIONS

Patients with a severer psoriasis tended to have higher blood β2M levels and severer inflammatory state. In the systemic inflammation indexes, the level of blood β2M affected the risk of hypertension and diabetes, and hsCRP affected the risk of arthritis in patients with psoriasis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Yawalkar, Nikhil

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1471-1753

Publisher:

Taylor & Francis

Language:

English

Submitter:

Pubmed Import

Date Deposited:

29 Jul 2024 12:42

Last Modified:

29 Jul 2024 12:52

Publisher DOI:

10.1080/09546634.2024.2377665

PubMed ID:

39069294

Uncontrolled Keywords:

ESR Psoriasis cardiovascular disease hsCRP systemic inflammation β2-microglobulin

BORIS DOI:

10.48350/199352

URI:

https://boris.unibe.ch/id/eprint/199352

Actions (login required)

Edit item Edit item
Provide Feedback